Cited by 2,070T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersHIV Research and Treatment

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Open access

Im, Se Jin, Hashimoto, Masao, Gerner, Michael Y., Lee, Junghwa, Kissick, Haydn T., Burger, Matheus C., Shan, Qiang, Hale, J. Scott, Lee, Judong, Nasti, Tahseen H., Sharpe, Arlene H., Freeman, Gordon J., Germain, Ronald N., Nakaya, Helder I., Xue, Hai-Hui, Ahmed, Rafi·2016·Nature

DOI 10.1038/nature19330PMC PMC5297183

Open this paper in CoChat — free account

Abstract

Chronic viral infections are characterized by a state of CD8+ T-cell dysfunction that is associated with expression of the programmed cell death 1 (PD-1) inhibitory receptor. A better understanding of the mechanisms that regulate CD8+ T-cell responses during chronic infection is required to improve immunotherapies that restore function in exhausted CD8+ T cells. Here we identify a population of virus-specific CD8+ T cells that proliferate after blockade of the PD-1 inhibitory pathway in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These LCMV-specific CD8+ T cells expressed the PD-1 inhibitory receptor, but also expressed several costimulatory molecules such as ICOS and CD28. This CD8+ T-cell subset was characterized by a unique gene signature that was related to that of CD4+ T follicular helper (T FH) cells, CD8+ T cell memory precursors and haematopoietic stem cell progenitors, but that was distinct from that of CD4+ T H 1 cells and CD8+ terminal effectors. This CD8+ T-cell population was found only in lymphoid tissues and resided predominantly in the T-cell zones along with naive CD8+ T cells. These PD-1+CD8+ T cells resembled stem cells during chronic LCMV infection, undergoing self-renewal and also differentiating into the terminally exhausted CD8+ T cells that were present in both lymphoid and non-lymphoid tissues. The proliferative burst after PD-1 blockade came almost exclusively from this CD8+ T-cell subset. Notably, the transcription factor TCF1 had a cell-intrinsic and essential role in the generation of this CD8+ T-cell subset. These findings provide a better understanding of T-cell exhaustion and have implications in the optimization of PD-1-directed immunotherapy in chronic infections and cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature19330

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Toll-Like Receptors
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citation
Follicular Helper CD4 T Cells (T FH )
Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
Self-citation
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citation
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Self-citation
Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription Factor
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,677
Self-citation

Show all 37 references

Sorted by citations

Items 801–900 of 1,003

Cancer immunotherapy–related adverse events: causes and challenges
Blidner, A. G., Choi, J. N., Cooksley, T., Dougan, M. L., Glezerman, I. G., Ginex, P., Girotra, M., Gupta, D., Johnson, D. B., Shannon, V. R., et al. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05705-5 · Cited by 34
Latest evidence on immunotherapy for cholangiocarcinoma (Review)
Guo, X., & Shen, W. (2020) · Oncology Letters · doi:10.3892/ol.2020.12244 · Cited by 33
Urinary detection of early responses to checkpoint blockade and of resistance to it via protease-cleaved antibody-conjugated sensors
Mac, Q. D., Sivakumar, A., Phuengkham, H., Xu, C., Bowen, J. R., Su, F., Stentz, S. Z., Sim, H., Harris, A. M., Li, T. T., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00852-y · Cited by 35
Dichotomous Roles of Programmed Cell Death 1 on HIV-Specific CXCR5+ and CXCR5− CD8+ T Cells during Chronic HIV Infection
Jiao, Y., Yang, H.-G., Huang, H.-H., Tu, B., Xing, S.-J., Mao, L., Xia, W., He, R., Zhang, J.-Y., Xu, R.-N., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01786 · Cited by 32
The pursuit of transplantation tolerance: new mechanistic insights
Gupta, P. K., Mcintosh, C. M., Chong, A. S., & Alegre, M. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0203-7 · Cited by 31
Biomechanics of T Cell Dysfunctions in Chronic Diseases
Gunasinghe, S. D., Peres, N. G., Goyette, J., & Gaus, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.600829 · Cited by 33
A novel memory-like Tfh cell subset is precursor to effector Tfh cells in recall immune responses
Han, F., Zhao, Z., Zhao, X., Bai, X., Fu, W., Zheng, L., Kang, B., Wang, X., Zhang, Z., & Dong, C. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221927 · Cited by 33
Induction of immortal-like and functional CAR T cells by defined factors
Wang, L., Jin, G., Zhou, Q., Liu, Y., Zhao, X., Li, Z., Yin, N., & Peng, M. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232368 · Cited by 32
PPP2R1A mutations portend improved survival after cancer immunotherapy
Dai, Y., Knisely, A. T., Yano, M., Dang, M., Hinchcliff, E., Lee, S., Welp, A. M., Chelvanambi, M., Lastrapes, M. J., Liu, H., et al. (2025) · Nature · doi:10.1038/s41586-025-09203-8 · Cited by 32
Overcoming CD8+ T-Cell Exhaustion in Viral Hepatitis: Lessons from the Mouse Model and Clinical Perspectives
Wieland, D., Hofmann, M., & Thimme, R. (2017) · Digestive Diseases · doi:10.1159/000456584 · Cited by 32
CXCR5+CD8+ T cells could induce the death of tumor cells in HBV-related hepatocellular carcinoma
Jin, Y., Lang, C., Tang, J., Geng, J., Song, H., Sun, Z., & Wang, J. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.009 · Cited by 32
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection
Desikan, R., Raja, R., & Dixit, N. M. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008064 · Cited by 33
Applications of Single-Cell Omics to Dissect Tumor Microenvironment
Guo, T., Li, W., & Cai, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.548719 · Cited by 33
The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient Outcome
Foroutan, M., Molania, R., Pfefferle, A., Behrenbruch, C., Scheer, S., Kallies, A., Speed, T. P., Cursons, J., & Huntington, N. D. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0137 · Cited by 35
TGF-β promotes stem-like T cells via enforcing their lymphoid tissue retention
Ma, C., Wang, L., Liao, W., Liu, Y., Mishra, S., Li, G., Zhang, X., Qiu, Y., Lu, Q., & Zhang, N. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211538 · Cited by 31
Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8+ T cells
Riegel, D., Romero-Fernández, E., Simon, M., Adenugba, A., Singer, K., Mayr, R., Weber, F., Kleemann, M., Imbusch, C. D., Kreutz, M. P., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.029 · Cited by 35
Tumor lysates-constructed hydrogel to potentiate tumor immunotherapy
Chen, X., Jiang, Z., Lin, Y., Yu, C., Nie, X., Xu, G., Xu, W., Jiang, Y., & Luan, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.005 · Cited by 32
Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity
Rivera, G. O. R., Dwyer, C. J., Knochelmann, H. M., Smith, A. S., Aksoy, B. A., Cole, A. C., Wyatt, M. M., Kumaresan, S., Thaxton, J. E., Lesinski, G. B., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0801 · Cited by 30
Cell-Intrinsic CD38 Expression Sustains Exhausted CD8 + T Cells by Regulating Their Survival and Metabolism during Chronic Viral Infection
DeRogatis, J. M., Neubert, E. N., Viramontes, K. M., Henriquez, M. L., Nicholas, D., & Tinoco, R. (2023) · Journal of Virology · doi:10.1128/jvi.00225-23 · Cited by 30
Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice
Onyshchenko, K., Luo, R., Guffart, E., Gaedicke, S., Grosu, A., Firat, E., & Niedermann, G. (2023) · Nature Communications · doi:10.1038/s41467-023-37825-x · Cited by 31
Loss of PBAF promotes expansion and effector differentiation of CD8+ T cells during chronic viral infection and cancer
Kharel, A., Shen, J., Brown, R. J., Chen, Y., Nguyen, C. P., Alson, D., Bluemn, T., Fan, J., Gai, K., Zhang, B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112649 · Cited by 32
Single-cell profiling reveals unique features of diabetogenic T cells in anti-PD-1-induced type 1 diabetes mice
Collier, J. L., Pauken, K. E., Lee, C. A. A., Patterson, D. G., Markson, S. C., Conway, T. S., Fung, M. E., France, J. A., Mucciarone, K., Lian, C. G., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221920 · Cited by 33
Self-citation
T cell fate decisions during memory cell generation with aging
Sturmlechner, I., Jain, A. K., Mu, Y., Weyand, C. M., & Goronzy, J. J. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101800 · Cited by 32
Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
Ziblat, A., Horton, B. L., Higgs, E. F., Hatogai, K., Martinez, A., Shapiro, J. W., Kim, D. E., Zha, Y., Sweis, R. F., & Gajewski, T. F. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114141 · Cited by 31
Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy
Hou, Y., Žák, J., Shi, Y., Pratumchai, I., Dinner, B., Wang, W., Qin, K., Weber, E. W., Teijaro, J. R., & Wu, P. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0089 · Cited by 33
Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironment
Green, W. D., Gomez, A., Plotkin, A. L., Pratt, B. M., Merritt, E. F., Mullins, G. N., Kren, N. P., Modliszewski, J. L., Zhabotynsky, V., Woodcock, M. G., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.030 · Cited by 34
Lymph nodes fuel KLF2-dependent effector CD8+ T cell differentiation during chronic infection and checkpoint blockade
Tsui, C., Heyden, L., Wen, L., de Graça, C. G., Potemkin, N., Frolov, A., Rawlinson, D., Qin, L., Wimmer, V. C., Hadian-Jazi, M., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02276-7 · Cited by 37
Epigenetic regulation of T cell exhaustion in cancer
Kang, T. G., Johnson, J. T., Zebley, C. C., & Youngblood, B. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00883-y · Cited by 36
New challenges in therapeutic vaccines against HIV infection
Leal, L., Lucero, C., Gatell, J. M., Gallart, T., Plana, M., & García, F. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1322513 · Cited by 33
CD8+ T Cell Responses to Toxoplasma gondii: Lessons from a Successful Parasite
Tsitsiklis, A., Bangs, D. J., & Robey, E. A. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.08.005 · Cited by 31
CD8+ T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer
Li, Q., Zhang, D., He, W., Chen, T., Yan, Z., Gao, X., Chen, L., Zheng, X. W., Xu, B., Lu, B., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11828 · Cited by 32
The transcription factor BCL-6 controls early development of innate-like T cells
Gioulbasani, M., Γαλάρας, Α., Grammenoudi, S., Moulos, P., Dent, A. L., Sigvardsson, M., Hatzis, P., Kee, B. L., & Verykokakis, M. (2020) · Nature Immunology · doi:10.1038/s41590-020-0737-y · Cited by 30
Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss
Xiong, S., Zhu, D. Y., Liang, B., Li, M., Pan, W., He, J., Wang, H., Sutter, K., Dittmer, U., Lu, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103464 · Cited by 32
CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
Mortezaee, K., & Majidpoor, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864298 · Cited by 34
Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs
Li, Z., Bu, J., Zhu, X., Zhou, H., Ren, K., Chu, P. K.-H., Li, L., Hu, X., & Ding, X. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212761 · Cited by 31
Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells
LaPorte, K. M., Hernandez, R., Savio, A. S., & Malek, T. R. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006611 · Cited by 30
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma
Dizman, N., Govindarajan, A., Zengin, Z. B., Meza, L., Tripathi, N., Sayegh, N., Castro, D. V., Chan, E. H., Lee, K. O., Prajapati, S. R., et al. (2023) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2023.06.004 · Cited by 29
Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes
Franzese, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312848 · Cited by 29
Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation
Dikiy, S., Ghelani, A. P., Levine, A. G., Martis, S., Giovanelli, P., Wang, Z.-M., Beroshvili, G., Pritykin, Y., Krishna, C., Huang, X. J., et al. (2025) · Nature Immunology · doi:10.1038/s41590-024-02075-6 · Cited by 36
Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy
Zou, D., Li, X. C., & Chen, W. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01321-7 · Cited by 30
Regulation of T cell exhaustion and stemness: molecular mechanisms and implications for cancer immunotherapy
Chen, Z., Zhu, Z., Hu, T., Yao, C., & Wu, T. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01378-4 · Cited by 37
Conversations that count: Cellular interactions that drive T cell fate
Duckworth, B. C., & Groom, J. R. (2021) · Immunological Reviews · doi:10.1111/imr.12945 · Cited by 32
Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
McAuliffe, J., Chan, H. F., Noblecourt, L., Ramirez-Valdez, R. A., Almeida, V. P., Zhou, Y., Pollock, E., Cappuccini, F., Redchenko, I., Hill, A. V. S., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003218 · Cited by 33
Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice
Garcia, M. G., Deng, Y., Murray, C. E., Reyes, R. M., Padron, A. S., Bai, H., Kancharla, A., Gupta, H. B., Shen-Orr, S. S., & Curiel, T. J. (2022) · Aging and Cancer · doi:10.1002/aac2.12045 · Cited by 29
Elastin content of the scleral spur, trabecular mesh, and sclera.
Moses, R. A., Grodzki, W. J., STARCHER, B. C., & Galione, M. J. (1978) · PubMed · Cited by 30
Autoimmune CD4+ T cells fine-tune TCF1 expression to maintain function and survive persistent antigen exposure during diabetes
Aljobaily, N. A., Allard, D., Perkins, B., Raugh, A., Galland, T., Jing, Y., Stephens, W. Z., Bettini, M. L., Hale, J. S., & Bettini, M. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.016 · Cited by 30
Self-citation
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target
Cid, L. L., Wong, J., Botana, I. F., Paul, Y., Wierz, M., Pilger, L.-M., Floerchinger, A., Tan, C. L., Gonder, S., Pagano, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61822-x · Cited by 33
Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature
Watanabe, T., Firat, E., Scholber, J., Gaedicke, S., Heinrich, C., Luo, R., Ehrat, N., Multhoff, G., Schmitt-Graeff, A. H., Grosu, A., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02587-8 · Cited by 30
Analysis of Ferroptosis-Mediated Modification Patterns and Tumor Immune Microenvironment Characterization in Uveal Melanoma
Jin, Y., Wang, Z., He, D., Zhu, Y., Gong, L., Xiao, M., Chen, X., & Cao, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.685120 · Cited by 30
Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
Miao, K., Zhang, X., Wang, H., Si, X., Ni, J., Zhong, W., Zhao, J., Xu, Y., Chen, M., Pan, R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912180 · Cited by 29
Peripheral blood lymphocyte subsets are associated with the clinical outcomes of prostate cancer patients
Mao, F., Yang, C., Luo, W., Wang, Y., Xie, J., & Wang, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109287 · Cited by 30
Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1 + CD8 + T cells in HCC via blocking VEGFR2
Mei, Z., Gao, X., Pan, C., Wu, Q., Wang, S., Qian, J., Xu, Z., Xu, K., Zhou, L., & Zhen, S. (2023) · Cancer Science · doi:10.1111/cas.15719 · Cited by 29
Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells
Nakashima, H., Alayo, Q. A., Penaloza‐MacMaster, P., Freeman, G. J., Kuchroo, V. K., Reardon, D. A., Fernández, S., Caligiuri, M. A., & Chiocca, E. A. (2018) · Scientific Reports · doi:10.1038/s41598-017-18540-2 · Cited by 29
Self-citation
Charting the Roadmap of T Cell Exhaustion
Chu, T., & Zehn, D. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.019 · Cited by 30
Determinants of anti-PD1 response and resistance in clear cell renal cell carcinomaPreprint
Au, L., Hatipoglu, E., de Massy, M. R., Litchfield, K., Rowan, A., Thompson, R. H., Schnidrig, D., Byrne, F., Beattie, G., Horswell, S. D., et al. (2021) · medRxiv · doi:10.1101/2021.03.19.21253661 · Cited by 29
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
Ali, L. R., Lenehan, P. J., Cardot‐Ruffino, V., Costa, A. D., Katz, M. H. G., Bauer, T. W., Nowak, J. A., Wolpin, B. M., Abrams, T. A., Patel, A. K., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1444 · Cited by 28
Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies
Roussot, N., Kaderbhaï, C., & Ghiringhelli, F. (2025) · Cancers · doi:10.3390/cancers17050906 · Cited by 29
PD-1 and CTLA-4: Two checkpoints, one pathway?
Walker, L. S. K. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan3864 · Cited by 31
Here, there and everywhere: T follicular helper cells on the move
Ma, C. S., & Phan, T. G. (2017) · Immunology · doi:10.1111/imm.12793 · Cited by 30
Potassium shapes antitumor immunity
Baixauli, F., Villa, M., & Pearce, E. L. (2019) · Science · doi:10.1126/science.aaw8800 · Cited by 27
The elusive identity of CXCR5+ CD8 T cells in viral infection and autoimmunity: Cytotoxic, regulatory, or helper cells?
Fousteri, G., & Kuka, M. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.01.007 · Cited by 28
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer
Bocchialini, G., Lagrasta, C. A. M., Madeddu, D., Mazzaschi, G., Marturano, D., Sogni, F., Silini, E. M., Gnetti, L., Becchi, G., Rusca, M., et al. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa098 · Cited by 28
Identification of a T-bethi Quiescent Exhausted CD8 T Cell Subpopulation That Can Differentiate into TIM3+CX3CR1+ Effectors and Memory-like Cells
Raju, S., Xia, Y., Dániel, B., Yost, K. E., Bradshaw, E., Tonc, E., Verbaro, D., Kometani, K., Yokoyama, W. M., Kurosaki, T., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001348 · Cited by 31
Self-Renewing Islet TCF1+ CD8 T Cells Undergo IL-27–Controlled Differentiation to Become TCF1− Terminal Effectors during the Progression of Type 1 Diabetes
Ciecko, A. E., Schauder, D., Foda, B. M., Петрова, Г. В., Kasmani, M. Y., Burns, R., Lin, C., Drobyski, W. R., Cui, W., & Chen, Y. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100362 · Cited by 27
Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies
Ronen, D., Bsoul, A., Lotem, M., Abedat, S., Yarkoni, M., Amir, O., & Asleh, R. (2022) · Vaccines · doi:10.3390/vaccines10040540 · Cited by 29
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8 + T cell infiltration and functional transition
Yu, A., Hu, J., Fu, L., Huang, G., Deng, D., Zhang, M., Wang, Y., Shu, G., Jing, L., Li, H., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007230 · Cited by 30
Interleukin 21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)–Specific CD8+ T Cells in Chronic HBV Infection
Tang, L., Chen, C., Gao, X., Zhang, W., Yan, X., Zhou, Y., Guo, L., Zheng, X., Wang, W., Yang, F., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy576 · Cited by 28
Metabolic Control of Memory T-Cell Generation and StemnessPreprint
Raynor, J. L., Chapman, N. M., & Chi, H. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037770 · Cited by 28
PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells
Viramontes, K. M., Neubert, E. N., DeRogatis, J. M., & Tinoco, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869768 · Cited by 27
TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response
León-Rodríguez, S. G. D., Aguilar-Flores, C., Gajón, J. A., Juárez-Flores, Á., Mantilla, A., Gerson-Cwilich, R., Martínez‐Herrera, J. F., Osorno, D. A. V., Gutiérrez-Quiroz, C. T., Buenaventura‐Cisneros, S., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008739 · Cited by 27
Combination radiation and αPD-L1 enhance tumor control by stimulating CD8+ PD-1+ TCF-1+ T cells in the tumor-draining lymph node
Shen, Y., Connolly, E. C., Aiello, M., Zhou, C., Chappa, P., Song, H., Tippitak, P., Clark, T. Y., Cardenas, M. A., Prokhnevska, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58510-1 · Cited by 27
Self-citation
PD-1 is requisite for skin TRM cell formation and specification by TGFβ
Devi, K. S. P., Wang, E., Jaiswal, A., Konieczny, P., Kim, T., Nirschl, C. J., Verma, A., Liu, Y., Milczanowski, J., Christo, S. N., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02228-1 · Cited by 27
Self-citation
Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions
Chae, Y. K., Oh, M. S., & Giles, F. J. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0354 · Cited by 28
2B4 but not PD-1 blockade improves mortality in septic animals with preexisting malignancy
Chen, C., Xue, M., Zhang, W., Xie, J., Coopersmith, C. M., & Ford, M. L. (2019) · JCI Insight · doi:10.1172/jci.insight.127867 · Cited by 26
Integrative network modeling reveals mechanisms underlying T cell exhaustion
Bolouri, H., Young, M. H., Beilke, J. N., Johnson, R., Fox, B. A., Huang, L., Santini, C. C., Hill, C. M., de Vries, A.-R. V. D. V., Shannon, P. T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58600-8 · Cited by 27
Trib1 regulates T cell differentiation during chronic infection by restraining the effector program
Rome, K., Stein, S. J., Kurachi, M., Petrovic, J., Schwartz, G. W., Mack, E. A., Uljon, S., Wu, W. W., DeHart, A. G., McClory, S., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190888 · Cited by 26
Unravelling the heterogeneity and dynamic relationships of tumor-infiltrating T cells by single-cell RNA sequencing analysis
Yu, X., Zhang, L., Chaudhry, A., Rapaport, A. S., & Ouyang, W. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.6mr0320-234r · Cited by 25
Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8+ T Cells
Sun, R., Wu, Y., Zhou, H., Wu, Y., Yang, Z., Gu, Y., Jiang, J., Lu, B., & Zhu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640224 · Cited by 29
Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer
Su, D., Wu, G., Xiong, R., Sun, X., Xu, M., Mei, Y., & Wu, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.634059 · Cited by 26
Design of PD-1-decorated nanocages targeting tumor-draining lymph node for promoting T cell activation
Kim, G. B., Sung, H.-D., Nam, G., Kim, W., Kim, S., Kang, D., Lee, E. J., & Kim, I.-S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.038 · Cited by 27
Prognostic Impact of Memory CD8(+) T Cells on Immunotherapy in Human Cancers: A Systematic Review and Meta-Analysis
Jin, Y., Tan, A., Feng, J., Xu, Z., Wang, P., Ruan, P., Luo, R., Weng, Y., & Peng, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698076 · Cited by 28
Programmed death 1 expressing CD8+CXCR5+ follicular T cells constitute effector rather than exhaustive phenotype in patients with chronic hepatitis B
Khanam, A., Tang, L., & Kottilil, S. (2021) · Hepatology · doi:10.1002/hep.32210 · Cited by 27
Immunotherapy and therapeutic vaccines for chronic HBV infection
Lang‐Meli, J., Neumann‐Haefelin, C., & Thimme, R. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.10.002 · Cited by 27
MicroRNA-29a attenuates CD8 T cell exhaustion and induces memory-like CD8 T cells during chronic infection
Stelekati, E., Cai, Z., Manne, S., Chen, Z., Beltra, J., Buchness, L. A., Leng, X., Ristin, S., Nzingha, K., Ekshyyan, V., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106083119 · Cited by 24
Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control
Perdomo-Celis, F., Passaes, C., Monceaux, V., Volant, S., Boufassa, F., de Truchis, P., Marcou, M., Bourdic, K., Weiss, L., Jung, C., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 27
Exhaustion of CD39-Expressing CD8+ T Cells in Crohn’s Disease Is Linked to Clinical Outcome
Globig, A.-M., Mayer, L., Heeg, M., Andrieux, G., Ku, M., Otto-Mora, P., Hipp, A. V., Zoldan, K., Pattekar, A., Rana, N., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.045 · Cited by 30
Continuous Expression of Interferon Regulatory Factor 4 Sustains CD8 + T Cell Immunity against Tumor
Yu, A., Fu, J., Yin, Z. Q., Yan, H. M., Xiao, X., Zou, D., Zhang, X., Zu, X., Li, X. C., & Chen, W. (2023) · Research · doi:10.34133/research.0271 · Cited by 28
CXCR5+CD8+ T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma
Tang, J.-H., Zha, J., Guo, X., Shi, P., & Xu, B. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.06.020 · Cited by 27
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells—Letter
Thelen, M., Lechner, A., Wennhold, K., von Bergwelt‐Baildon, M., & Schlößer, H. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0873 · Cited by 27
The Tumor-Specific Immune Landscape in HPV+ Head and Neck Cancer
Conarty, J. P., & Wieland, A. (2023) · Viruses · doi:10.3390/v15061296 · Cited by 27
Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma
Pulliam, T. H., Jani, S., Jing, L., Ryu, H., Jojic, A., Shasha, C., Zhang, J., Kulikauskas, R. M., Church, C. D., Garnett‐Benson, C., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101412 · Cited by 28
Stem-like CD8+ T cells in cancer
Steiner, C., Denlinger, N., Huang, X., & Yang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1426418 · Cited by 28
Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours
Ni, L. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1817 · Cited by 26
ICOS limits memory-like properties and function of exhausted PD-1 + CD8 T cells
Humblin, É., Korpas, I., Prokhnevska, N., Vaidya, A. B., Filipescu, D., Lu, J., van der Heide, V., Fraga, C. A. D. C., Bobrowski, T., Marks, A. R., et al. (2024) · Immunity · doi:10.1016/j.immuni.2025.06.001 · Cited by 26
Self-citation
Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C
Osuch, S., Laskus, T., Berak, H., Perlejewski, K., Metzner, K. J., Paciorek, M., Radkowski, M., & Cortés, K. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-73137-6 · Cited by 26
Large-scale, three-dimensional tissue cytometry of the human kidney: a complete and accessible pipeline
Ferkowicz, M. J., Winfree, S., Sabo, A. R., Kamocka, M. M., Khochare, S., Barwinska, D., Eadon, M. T., Cheng, Y., Phillips, C. L., Sutton, T. A., et al. (2021) · Laboratory Investigation · doi:10.1038/s41374-020-00518-w · Cited by 26
Role of kynurenine in promoting the generation of exhausted CD8+ T cells in colorectal cancer.
Wu, D., & Zhu, Y. (2021) · PubMed · Cited by 26
CXCR5+CD8+ T Cells: A Review of Their Antibody Regulatory Functions and Clinical Correlations
Elzein, S. M., Zimmerer, J. M., Han, J. L., Ringwald, B. A., & Bumgardner, G. L. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100082 · Cited by 26
Molecular Basis of the Differentiation and Function of Virus Specific Follicular Helper CD4+ T Cells
Huang, Q., Hu, J., Tang, J., Xu, L., & Ye, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00249 · Cited by 28
XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections
Domenjo‐Vila, E., Casella, V., Iwabuchi, R., Fossum, E., Pedragosa, M., Castellví, Q., Rica, P. C., Kaisho, T., Terahara, K., Bocharov, G. A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112123 · Cited by 26

Authors: Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., Sharpe, A. H., Freeman, G. J., Germain, R. N., Nakaya, H. I., Xue, H.-H., & Ahmed, R.
Affiliations: Emory University (US)
National Institutes of Health (US)
University of Iowa (US)
Brigham and Women's Hospital (US)
Harvard University (US)
Universidade de São Paulo (BR)
Corresponding author: Ahmed, Rafi
ORCID: Im, Se Jin
Hashimoto, Masao
Gerner, Michael Y.
Lee, Junghwa
Kissick, Haydn T.
Shan, Qiang
Hale, J. Scott
Lee, Judong
Nasti, Tahseen H.
Sharpe, Arlene H.
Freeman, Gordon J.
Germain, Ronald N.
Nakaya, Helder I.
Xue, Hai-Hui
Ahmed, Rafi
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2016-08-02
Volume: 537
Issue: 7620
Pages: 417-421
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature19330
PMC: PMC5297183
OpenAlex: W2506616866
Cited by: 2,070
References: 37
Citations by year: 2026: 224 · 2025: 245 · 2024: 268 · 2023: 264 · 2022: 248 · 2021: 252 · 2020: 223 · 2019: 154 · 2018: 101 · 2017: 75 · 2016: 13
FWCI: 69.19
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Institutes of Health (n01ai30048-10-0-1)
National Institute of Allergy and Infectious Diseases (N01 AI030048, P01AI080192, P01AI056299, R01AI030048, R01AI121080, R01AI112579)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: CD8+ T cells, PD-1, T cell exhaustion, lymphocytic choriomeningitis virus, chronic viral infection, B cell follicles, T follicular helper cells, PD-L1 blockade, anti-PD-1 therapy, HIV, virus control, costimulatory molecules
MeSH terms: Cell Self Renewal, Animals, Cell Differentiation, Female, T-Lymphocytes, Helper-Inducer, Hematopoietic Stem Cells, Immunotherapy, Lymphocytic Choriomeningitis, Lymphocytic choriomeningitis virus, T-Lymphocyte Subsets, CD28 Antigens, CD8-Positive T-Lymphocytes, Cell Proliferation, Mice, Hepatocyte Nuclear Factor 1-alpha, Inducible T-Cell Co-Stimulator Protein, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks